0001104659-22-075935.txt : 20220629
0001104659-22-075935.hdr.sgml : 20220629
20220629213633
ACCESSION NUMBER: 0001104659-22-075935
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20220629
DATE AS OF CHANGE: 20220629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sim Brandon
CENTRAL INDEX KEY: 0001813532
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37392
FILM NUMBER: 221056335
MAIL ADDRESS:
STREET 1: C/O APOLLO MEDICAL HOLDINGS, INC.
STREET 2: 1668 S. GARFIELD AVENUE, 3RD FLOOR
CITY: ALHAMBRA
STATE: CA
ZIP: 91801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc.
CENTRAL INDEX KEY: 0001083446
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 870042699
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1668 S. GARFIELD AVENUE
STREET 2: 2ND FLOOR
CITY: ALHAMBRA
STATE: CA
ZIP: 91801
BUSINESS PHONE: (626) 282-0288
MAIL ADDRESS:
STREET 1: 1668 S. GARFIELD AVENUE
STREET 2: 2ND FLOOR
CITY: ALHAMBRA
STATE: CA
ZIP: 91801
FORMER COMPANY:
FORMER CONFORMED NAME: SICLONE INDUSTRIES INC
DATE OF NAME CHANGE: 19990413
4
1
tm2220100-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-27
0
0001083446
Apollo Medical Holdings, Inc.
AMEH
0001813532
Sim Brandon
1668 S. GARFIELD AVE., 2ND FL.
ALHAMBRA
CA
91801
0
1
0
0
Co- Chief Executive Officer
Common Stock
2022-06-27
4
A
0
108560
0
A
292623
D
Common Stock
2022-06-27
4
A
0
198511
0
A
491134
D
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the following dates, the shares of restricted stock shall vest in four equal annual installments commencing on the first anniversary of June 27, 2022.
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, vesting of the restricted shares is based on achievement of pre-established financial performance goals on or before December 31, 2024.
/s/ Brandon Sim
2022-06-29